A bioactive-guided investigation of the hydro-ethanolic extract of aerial parts of Aristeguietia glutinosa Lam. resulted in the isolation of two diterpenoids, (+)-15-hydroxy-labd-7-en-17-al (1) and (+)-13,14,15,16-tetranor-labd-7-en-l7,12-olide (2), as the anti-Trypanosoma cruzi active principles. The structures of 1 and 2 were determined by spectroscopic analysis. The hydro-ethanolic extract showed anti-T. cruzi activity (IC50= 19.6 μg/mL) whereas the isolated compounds 1 and 2 were near to seven- and one and a half-fold (IC50= 3.0 and 15.6 μg/mL), respectively more active than the original extract. Labdene 1, equipotent as the reference compound (Nifurtimox), displayed low hemolytic activity, low toxicity against murine macrophages, and absence of mutagenicity. These results support the vernacular medicinal use of this plant as an anti-T. cruzi agent.
KingRM, RobinsonH. (1975) Studies in the Eupatorieae (Asteraceae), CXXXIX. A new genus, Aristeguietia. Phytologia, 30, 217–220.
2.
DukeJA, Bogenschutz-GodwinMJ, OttesenAR. (2008) Duke's handbook of medicinal plants of Latin America. Taylor Francis Inc, United States.
3.
SharmaOP, DawraRK, KuradaNP, SharmaPD. (1998) A review of the toxicosis and biological properties of the genus Eupatorium. Natural Toxins, 6, 1–14.
4.
WoerdenbagHJ. (1986) Eupatorium cannabinum L. A review emphasizing the sesquiterpene lactones and their biological activity. Pharmaceutisch Weekblad. Scientific Edition, 8, 245–251.
5.
Acosta-SolisM. (1992) Vademecum de plantas medicinales del Ecuador. Abya-Yala, Quito, Ecuador.
6.
ValenciaR, PitmanN, León-YánezS, JorgensenPM. (2000) Libro rojo de las plantas endémicas del Ecuador. Publicaciones del Herbario QCA de la Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
7.
El-SeediHR, OharaT, SataN, NishiyamaS., (2002) Antimicrobial diterpenoids from Eupatorium glutinosum (Asteraceae). Journal of Ethnopharmacology, 81, 293–296.
8.
El-SeediHR, SataN, TorssellKBG, NishiyamaS., (2002) New labdene iterpenes from Eupatorium glutinosum. Journal of Natural Products, 65, 728–729.
9.
AbadMJ, BermejoP, Sanchez PalominoS, ChiribogaX, CarrascoL., (1999) Antiviral activity of some South American medicinal plants. Phytotherapy Research, 13, 142–146.
10.
ChiribogaX, MiñoP. (2011) Data not published.
11.
Menna-BarretoRFS, SalomãoK, DantasAP, Santa-RitaRM, SoaresMJ, BarbosaHS, de CastroSL. (2009) Different cell death pathways induced by drugs in Trypanosoma cruzi: An ultrastructural study. Micron, 40, 157–168.
12.
UrbinaJA. (2009) Ergosterol biosynthesis and drug development for Chagas disease. Memórias do Instituto Oswaldo Cruz, 104, 311–318.
13.
UronesJG, MarcosIS, BasabeP, DiezD, GarridoNM, AlonsoC, OlivaIM, LithgowAM, MoroRF, SexmeroMJ, LopezC. (1994) Compounds with the labdane skeleton from Halimium viscosum. Phytochemistry, 35, 713–719.
14.
BenitezD, CabreraM, HernándezP, BoianiL, LavaggiML, Di MaioR, YaluffG, SernaE, TorresS, FerreiraME, Vera de BilbaoN, TorresE, Pérez-SilanesS, SolanoB, MorenoE, AldanaI, López de CeráinA, CerecettoH, GonzálezM, MongeA. (2011) 3-Trifluoromethylquinoxaline N, N’-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. Journal of Medicinal Chemistry, 54, 3624–3636.
15.
DewickPM. (2002) Medicinal natural products: A biosynthetic approach. John Wiley & Sons, Chichester, UK.
16.
JakupovicJ, SchusterA, WasshausenDC. (1991) Acetylenes and labdanes from Baccharis pedunculata. Phytochemistry, 30, 2785–2787.
17.
AbeM, OzawaY, UdaY, MorimitsuY, NakamuraY, OsawaT. (2006) A novel labdane-type trialdehyde from myoga (Zingiber mioga Roscoe) that potently inhibits human platelet aggregation and human 5-lipoxygenase. Bioscience Biotechnology & Biochemistry, 70, 2494–2500.
18.
AbeM, OzawaY, MorimitsuY, KubotaK. (2008) Mioganal, a novel pungent principle in myoga (Zingiber mioga Roscoe) and a quantitative evaluation of its pungency. Bioscience Biotechnology & Biochemistry, 72, 2681–2686.
19.
de las HerasB, HoultJR. (1994) Non-cytotoxic inhibition of macrophage eicosanoid biosynthesis and effects on leukocyte functions and reactive oxygen species of two novel anti-inflammatory plant diterpenoids. Planta Medica, 60, 501–506.
20.
AsiliJ, LambertM, ZieglerHL, StærkD, SairafianpourM, WittM, AsghariG, IbrahimiIS, JaroszewskiJW. (2004) Labdanes and isopimaranes from Platycladus orientalis and their effects on erythrocyte membrane and on Plasmodium falciparum growth in the erythrocyte host cells. Journal of Natural Products, 67, 631–637.
21.
SartorelliP, CarvalhoCS, ReimãoJQ, LorenziH, TemponeAG. (2010) Antitrypanosomal activity of a diterpene and lignans isolated from Aristolochia cymbifera. Planta Medica, 76, 1454–1456.
22.
GerpeA, AlvarezG, BenítezD, BoianiL, QuirogaM, HernándezP, SortinoM, ZacchinoS, GonzálezM, CerecettoH. (2009) 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene. Bioorganic & Medicinal Chemistry, 17, 7500–7509.
23.
MerlinoA, BenitezD, CampilloNE, PáezJA, TinocoLW, GonzálezM, CerecettoH. (2012) Amidines bearing benzofuroxan or benzimidazole 1,3-dioxide core scaffolds as Trypanosoma cruzi-inhibitors: structural basis for their interactions with cruzipain. MedChemCommun, 3, 90–101.
24.
BoianiM, MerlinoA, GerpeA, PorcalW, CroceF, DepaulaS, RodríguezMA, CerecettoH, GonzálezM. (2009) o-Nitroanilines as major metabolic products of anti-Trypanosoma cruzi 5-phenylethenylbenzofuroxans in microsomal and cytosolic fractions of rat hepatocytes and in whole parasitic cells. Xenobiotica, 39, 236–248.
25.
(a)PrajapatiVK, AwasthiK, GautamS, YadavTP, RaiM, SrivastavaON, SundarS., (2011) Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. Journal of Antimicrobial Chemotherapy, 66, 874–879;
26.
ReifferscheidG, HeilJ. (1996) Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data. Mutation Research, 369, 129–145.
27.
FernandezL, CalderónM, MartinelliM, StrumiaM, CerecettoH, GonzálezM, SilberJJ, SantoM. (2008) Evaluation of a new dendrimeric structure as prospective drugs carrier for intravenous administration of antichagasic active compounds. Journal of Physical Organic Chemistry, 21, 1079–1085.
28.
MerlinoA, BenitezD, ChavezS, Da CunhaJ, HernándezP, TinocoLW, CampilloNE, PáezJA, CerecettoH, GonzálezM. (2010) Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds. MedChemCommun, 1, 216–228.
29.
MaronDM, AmesBN. (1983) Revised methods for the Salmonella mutagenicity test. Mutation Research, 113, 173–215.
30.
ChuKC, PatelKM, LinAH, TaroneRE, LinhartMS, DunkelVC. (1981) Evaluating statistical analyses and reproducibility of microbial mutagenicity assays. Mutation Research, 85, 119–132.
